Renal dysfunction and high levels of hsCRP are additively associated with hard endpoints after percutaneous coronary intervention with drug eluting stents

被引:23
作者
Choi, Dong-Hyun
Park, Kyung Woo
Yang, Han-Mo
Lee, Hae-Young
Park, Jin-Shik
Kang, Hyun-Jai
Kim, Yong-Jin
Koo, Bon-Kwon
Oh, Byung-Hee
Park, Young-Bae
Kim, Hyo-Soo [1 ]
机构
[1] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea
关键词
Renal function; hsCRP; Drug eluting stent; Mortality plus MI; C-REACTIVE PROTEIN; CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR-DISEASE; HEART-DISEASE; OUTCOMES; IMPACT; INFLAMMATION; RISK; REVASCULARIZATION; PREDICTION;
D O I
10.1016/j.ijcard.2010.01.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Chronic kidney disease (CKD) and high C-reactive protein (CRP) are known risk factors of cardiovascular disease. In the drug eluting stent (DES) era, the relationship among CKD, CRP, and long-term outcomes after percutaneous coronary intervention (PCI) has not yet been demonstrated. We investigated the combined effects of renal dysfunction and CRP on outcomes in patients who underwent PCI using DES. Methods: A total of 1859 patients (mean age 64 +/- 10 years) who underwent PCI with DES between February 2003 and June 2006, were divided into 4 groups (quartile) according to estimated glomerular filtration rate (eGFR) and hsCRP at admission. Results: The composite of cumulative death and non-fatal myocardial infarction (mortality + MI) during median follow-up of 27 months, was significantly higher in the lowest eGFR quartile than in the other three groups (hazard ratio (HR) for mortality + MI: 3.32, 95% CI: 2.21-5.00, P < 0.001). Mortality + MI was also significantly higher in the highest hsCRP quartile (HR: 3.29, 95% CI: 2.02-5.37, P < 0.001). A combined analysis of mortality + MI on the basis of hsCRP and renal function showed the exaggerated hazard in the combined worst quartile of hsCRP and GFR (HR of the combined worst quartile, 10.876, 95% CI: 3.74-31.63, P < 0.001). Furthermore, both the lowest eGFR quartile and the highest hsCRP quartile were significantly associated with increased risk of stent thrombosis. In a multivariate analysis, low GFR and high hsCRP were independent predictors of mortality + MI after PCI with DES along with left ventricular dysfunction, diabetes, and left main disease. Conclusions: In an unselected cohort of patients receiving PCI with DES, poor renal function and high hsCRP were additively associated with a higher risk of hard endpoints and were independent predictors of mortality + MI even after correction for other factors. Our data suggest the importance of systemic factors on mortality even in the DES era. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:174 / 181
页数:8
相关论文
共 31 条
[1]   End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link? [J].
Arici, M ;
Walls, J .
KIDNEY INTERNATIONAL, 2001, 59 (02) :407-414
[2]   Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting [J].
Azar, RR ;
Prpic, R ;
Ho, KKL ;
Kiernan, FJ ;
Shubrooks, SJ ;
Baim, DS ;
Popma, JJ ;
Kuntz, RE ;
Cohen, DJ .
AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (05) :485-489
[3]   The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions [J].
Best, PJM ;
Lennon, R ;
Ting, HH ;
Bell, MR ;
Rihal, CS ;
Holmes, DR ;
Berger, PB .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (07) :1113-1119
[4]   Impact of mild or moderate chronic kidney disease on the frequency of restenosis - Results from the PRESTO trial [J].
Best, PJM ;
Berger, PB ;
Davis, BR ;
Grines, CL ;
Sadeghi, HM ;
Williams, BA ;
Willerson, JT ;
Granett, JR ;
Holmes, DR .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (09) :1786-1791
[5]   Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention [J].
Chew, DP ;
Bhatt, DL ;
Robbins, MA ;
Penn, MS ;
Schneider, JP ;
Lauer, MS ;
Topol, EJ ;
Ellis, SG .
CIRCULATION, 2001, 104 (09) :992-997
[6]  
COAST AJ, 2009, INT J CARDIOL, V131, P149
[7]   Clinical end points in coronary stent trials - A case for standardized definitions [J].
Cutlip, Donald E. ;
Windecker, Stephan ;
Mehran, Roxana ;
Boam, Ashley ;
Cohen, David J. ;
van Es, Gerrit-Anne ;
Steg, P. Gabriel ;
Morel, Marie-angele ;
Mauri, Laura ;
Vranckx, Pascal ;
McFadden, Eugene ;
Lansky, Alexandra ;
Hamon, Martial ;
Krucoff, Mitchell W. ;
Serruys, Patrick W. .
CIRCULATION, 2007, 115 (17) :2344-2351
[8]   Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease - Meta-analyses of prospective studies [J].
Danesh, J ;
Collins, R ;
Appleby, P ;
Peto, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (18) :1477-1482
[9]   The interaction of vascular inflammation and chronic kidney disease for the prediction of long-term death after percutaneous coronary intervention [J].
Fathi, RB ;
Gurm, HS ;
Chew, DP ;
Gupta, R ;
Bhatt, DL ;
Ellis, SG .
AMERICAN HEART JOURNAL, 2005, 150 (06) :1190-1197
[10]   Comparison of outcomes after percutaneous coronary revascularization with stents in patients with and without mild chronic renal insufficiency [J].
Gruberg, L ;
Weissman, NJ ;
Waksman, R ;
Laird, JR ;
Pinnow, EE ;
Wu, HS ;
Deible, R ;
Kent, KM ;
Pichard, AD ;
Satler, LF ;
Lindsay, J .
AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (01) :54-+